OBJECTIVE: We investigated whether or not the UCP1 -3826 A>G polymorphism is associated with obesity and related metabolic disorders in grade III obese patients. METHODS: 150 obese patients (body mass index ≥35 kg/m(2)) who were candidates for bariatric surgery were studied. Weight (kg), body mass index (kg/m(2)); fat free mass (kg), fat mass (kg), energy intake (kcal), level of physical activity, plasma levels of glucose, total cholesterol, low-density lipoprotein, high-density lipoprotein (HDL), triacylglycerols, and the prevalence of comorbidities associated with obesity were collected from medical records. Polymorphism rs1800592 genotyping was performed through allelic discrimination method in real time polymerase chain reaction using the TaqMan predesigned SNP Genotyping Assays kits. The t test was done to determine if genotypes of each polymorphism are associated with anthropometric and body composition variables. Linear regression models were used for age, sex, height, physical activity, and energy intake in weight and body composition variations (P < 0.05). RESULTS: Among these 150 individuals (47.2 ± 10.5 y, 80% women) the distribution of AA, AG, and GG was 41.3%, 45.3%, and 13.4%, respectively. Weight and body fat were lower in individuals who were carriers of a mutated allele G. It was observed that mutated homozygotes (GG) had a lower frequency of type 2 diabetes mellitus compared with those of wild allele (AA+AG). CONCLUSIONS: UCP1 -3826 A>G polymorphism is associated with weight, body fat mass, and risk of type 2 diabetes mellitus in obese individuals candidates for bariatric surgery.
OBJECTIVE: We investigated whether or not the UCP1 -3826 A>G polymorphism is associated with obesity and related metabolic disorders in grade III obesepatients. METHODS: 150 obesepatients (body mass index ≥35 kg/m(2)) who were candidates for bariatric surgery were studied. Weight (kg), body mass index (kg/m(2)); fat free mass (kg), fat mass (kg), energy intake (kcal), level of physical activity, plasma levels of glucose, total cholesterol, low-density lipoprotein, high-density lipoprotein (HDL), triacylglycerols, and the prevalence of comorbidities associated with obesity were collected from medical records. Polymorphism rs1800592 genotyping was performed through allelic discrimination method in real time polymerase chain reaction using the TaqMan predesigned SNP Genotyping Assays kits. The t test was done to determine if genotypes of each polymorphism are associated with anthropometric and body composition variables. Linear regression models were used for age, sex, height, physical activity, and energy intake in weight and body composition variations (P < 0.05). RESULTS: Among these 150 individuals (47.2 ± 10.5 y, 80% women) the distribution of AA, AG, and GG was 41.3%, 45.3%, and 13.4%, respectively. Weight and body fat were lower in individuals who were carriers of a mutated allele G. It was observed that mutated homozygotes (GG) had a lower frequency of type 2 diabetes mellitus compared with those of wild allele (AA+AG). CONCLUSIONS:UCP1 -3826 A>G polymorphism is associated with weight, body fat mass, and risk of type 2 diabetes mellitus in obese individuals candidates for bariatric surgery.
Authors: Ana Carolina Proença da Fonseca; Guilherme Proença da Fonseca; Bruna Marchesini; Danielle Dutra Voigt; Mario Campos Junior; Verônica Marques Zembrzuski; João Regis Ivar Carneiro; José Firmino Nogueira Neto; Pedro Hernan Cabello; Giselda Maria Kalil Cabello Journal: Obes Facts Date: 2020-04-23 Impact factor: 3.942
Authors: Raymond E Soccio; Zhenghui Li; Eric R Chen; Yee Hoon Foong; Kiara K Benson; Joanna R Dispirito; Shannon E Mullican; Matthew J Emmett; Erika R Briggs; Lindsey C Peed; Richard K Dzeng; Carlos J Medina; Jennifer F Jolivert; Megan Kissig; Satyajit R Rajapurkar; Manashree Damle; Hee-Woong Lim; Kyoung-Jae Won; Patrick Seale; David J Steger; Mitchell A Lazar Journal: J Clin Invest Date: 2017-02-27 Impact factor: 14.808
Authors: C F Nicoletti; M A S Pinhel; A Diaz-Lagares; F F Casanueva; A Jácome; V C Pinhanelli; B A P de Oliveira; A B Crujeiras; C B Nonino Journal: BMC Med Genomics Date: 2019-05-27 Impact factor: 3.063
Authors: Anna E Pravednikova; Sergey Y Shevchenko; Victor V Kerchev; Manana R Skhirtladze; Svetlana N Larina; Zaur M Kachaev; Alexander D Egorov; Yulii V Shidlovskii Journal: Mol Med Date: 2020-05-25 Impact factor: 6.354
Authors: Petros C Dinas; Eleni Nintou; Maria Vliora; Anna E Pravednikova; Paraskevi Sakellariou; Agata Witkowicz; Zaur M Kachaev; Victor V Kerchev; Svetlana N Larina; James Cotton; Anna Kowalska; Paraskevi Gkiata; Alexandra Bargiota; Zaruhi A Khachatryan; Anahit A Hovhannisyan; Mariya A Antonosyan; Sona Margaryan; Anna Partyka; Pawel Bogdanski; Monika Szulinska; Matylda Kregielska-Narozna; Rafał Czepczyński; Marek Ruchała; Anna Tomkiewicz; Levon Yepiskoposyan; Lidia Karabon; Yulii Shidlovskii; George S Metsios; Andreas D Flouris Journal: PLoS One Date: 2022-04-28 Impact factor: 3.752
Authors: Shahanas Chathoth; Mona H Ismail; Chittibabu Vatte; Cyril Cyrus; Zhara Al Ali; Khandaker Ahtesham Ahmed; Sadananda Acharya; Aisha Mohammed Al Barqi; Amein Al Ali Journal: BMC Med Genet Date: 2018-11-20 Impact factor: 2.103